What question did this study set out to answer?

To establish a small-scale, quality-controlled laboratory production protocol for a defined lytic bacteriophage cocktail targeting Pseudomonas aeruginosa and Staphylococcus aureus infections in burn wound patients.

March 19, 2009PLoS ONEOpen Access

Quality-Controlled Small-Scale Production of a Well-Defined Bacteriophage Cocktail for Use in Human Clinical Trials

View Full Paper

Ask AI

Bookmark

To establish a small-scale, quality-controlled laboratory production protocol for a defined lytic bacteriophage cocktail targeting Pseudomonas aeruginosa and Staphylococcus aureus infections in burn wound patients.
Screened an initial collection of 82 P. aeruginosa and 8 S. aureus phages against prevalent clinical burn center isolates to select three therapeutically relevant candidates (14/1, PNM, and ISP).
Purified the cocktail to eliminate endotoxins and conducted quality control testing including shelf-life stability, sterility, pyrogenicity, cytotoxicity, and transmission electron microscopy.
Performed genomic and proteomic sequencing on the selected phages to confirm the absence of toxin genes and temperate life cycle markers.
Selected three exclusively lytic phages—P. aeruginosa phages 14/1 (Myoviridae) and PNM (Podoviridae) and S. aureus phage ISP (Myoviridae)—that fulfilled all quality control thresholds for sterility, cytotoxicity, and endotoxin removal.
Genome and proteome analyses verified the absence of toxin-encoding genes and established close phylogenetic relationships to reference phages F8, phiKMV, and G1, respectively.

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

Translational study demonstrates quality-controlled production of a three-phage cocktail targeting burn wound pathogens, indicating feasibility for human clinical trials.

Cite This Study

Merabishvili et al. (2009) studied this question.

synapsesocial.com/papers/6a7ca65e3dbea9de816114c0 https://doi.org/10.1371/journal.pone.0004944

View Full Paper

Ask AI

Bookmark

Implication

Translational study demonstrates quality-controlled production of a three-phage cocktail targeting burn wound pathogens, indicating feasibility for human clinical trials.

Quality-Controlled Small-Scale Production of a Well-Defined Bacteriophage Cocktail for Use in Human Clinical Trials

Key Points

Discussion

Implication

Cite This Study

Quality-Controlled Small-Scale Production of a Well-Defined Bacteriophage Cocktail for Use in Human Clinical Trials

Key Points

Discussion

Implication

Cite This Study